In a week that started with a terrible attack on the Jewish community in Bondi and with ramifications nationally and globally – there is a need more than ever to lean on, strengthen and protect community. As we mourn each individual who needlessly lost their lives, it is communities which will carry their families through […]
New mechanism builds on Gavi COVAX Advance Market Commitment (AMC) cost-sharing arrangement Washington DC / Geneva, 26 July 2021 – COVAX and the World Bank will accelerate COVID-19 vaccine supply for developing countries through a new financing mechanism that builds on Gavi’s newly designed AMC cost-sharing arrangement. This allows AMC countries to purchase doses beyond the […]
Technology transfer agreements signed to enable expanded production of high-quality antigen rapid tests in Africa and Latin America Agreements signed with DCN Dx to transfer know-how to WAMA Diagnóstica (Brazil), and Bionote and Mologic to transfer know-how to DIATROPIX of the Institut Pasteur de Dakar (Senegal) Separate partnership between Viatris (South Africa) and Guangzhou Wondfo Biotech […]
GENEVA – The Global Fund to Fight AIDS, Tuberculosis and Malaria praised the decision by the Swiss Federal Council to make available CHF300 million to the Access to COVID-19 Tools (ACT) Accelerator – a ground-breaking global collaboration of leading public health agencies to accelerate the development, production, and equitable access to COVID-19 tests, treatments, and vaccines, […]
The Partnership for Vivax Elimination (PAVE) will support endemic countries in achieving their Plasmodium vivax (P. vivax) malaria elimination goals. PAVE will advance the development of quality-assured, child-friendly treatments for relapse prevention, and generate and consolidate evidence to support malaria-endemic countries in developing and implementing new strategies to eliminate P. vivax malaria. Geneva/Seattle, 14 July 2021 – The new Partnership […]
The signed advance purchase agreements will make doses available to COVAX starting from July to help address immediate and critical gaps in supply Addition of the Sinopharm and Sinovac vaccines, which have already been granted WHO Emergency Use Listing (EUL), further diversifies the Gavi-managed COVAX Facility portfolio, which now includes 11 vaccines and vaccine candidates […]
Geneva, 7 July 2021 – Unitaid welcomes new recommendations released by the World Health Organisation for the clinical care package for patients with severe or critical COVID-19, adding two medicines (tocilizumab and sarilumab). Having more treatment options is clearly of huge benefit, especially given the current concerning epidemiological situation around the world. Equitable access arrangements for medicines to treat […]
Geneva/New York/Oslo, 1 July 2021 – COVAX was built on the principle of equitable access to COVID-19 vaccines to protect the health of people all across the globe. That means protecting their lives and livelihoods, including their ability to travel and conduct trade. As travel and other possibilities begin to open up in some parts of […]
Harare, 1 July 2021 – UNICEF, Gavi, the Vaccine Alliance and WHO have partnered with the Ministry of Health and Child Care to launch a new vaccine campaign introducing typhoid conjugate vaccine (TCV) into the routine immunisation schedule across the country. The TCV campaign, the first of its kind in the region, was made possible through […]
The signed advance purchase agreement (APA) will make up to 414 million doses of the Clover vaccine candidate available to the COVAX Facility, pending WHO Emergency Use Listing (EUL) Supply will be available to self-financing participants of the COVAX Facility as well as lower-income economies eligible to be supported by the Gavi COVAX Advance market […]
Gavi, UNICEF and partners collaborate on nationwide introduction, which will see all children from the age of two months protected from pneumonia by 2022 The country has received 1.6 million doses of the vaccine procured through the Gavi Pneumococcal Advanced Market Commitment mechanism Anuradha Gupta: “Congratulations to the Government of Indonesia on this milestone, which will save […]
Gavi Board makes key strategic decisions to support Gavi’s 5.0 strategy of leaving no child behind through immunisation; doubles down on ambitious targets for COVAX New market-shaping strategy, alliances with civil society among measures aimed at reducing the number of children receiving no doses of vaccine, by 25% globally – by 2025 US$ 775 million […]
Geneva, 24 June 2021 – Global health leaders Gavi, the Vaccine Alliance and the Global Fund to Fight AIDS, Tuberculosis and Malaria have joined forces with the International Federation of Accountants (IFAC) to contribute to, and support, the implementation of robust accounting practices in the public health sector and to improve overall financial management of donor funds by implementing countries.Through […]
23 June 2021 – by Aurélia Nguyen, Managing Director, Office of the COVAX Facility COVAX’s latest supply forecast is now published. According to this latest assessment, the vaccines pillar of the ACT-Accelerator will have 1.9 billion doses available for supply by the end of 2021 and, thanks to a number of recently signed advance purchase agreements, now […]
